Evaluation of a multi-country medical oxygen program
Official title: Realist Evaluation and Learning in a Multi-country Medical OXYgen Program (REAL-MOXY)
Run by Murdoch Childrens Research Institute · NCT06087315 · Data updated 2026-11-12
This study is trying to see how medical oxygen is used in hospitals across nine countries to find ways to make it easier for patients, especially children with low oxygen levels, to get the help they need.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 0 Years to 15 Years |
| Sex | All |
| Enrollment | 1200 (estimated) |
| Sponsor | Murdoch Childrens Research Institute Academic / other |
| Locations | 3 sites (Phnom Penh and 2 other locations) |
| Status | Recruiting |
| Started | November 27, 2023 |
| Main results expected | December 2027 |
| Study ends | December 2027 |
| Registry record updated | July 8, 2026 |
| Trial ID | NCT06087315 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study include children admitted to healthcare facilities in the participating countries who are at risk of hypoxemia or related conditions.
✕Probably not a fit
Patients who are not admitted to the participating healthcare facilities or those who do not require oxygen therapy may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to assess the use of medical oxygen and pulse oximetry in healthcare facilities across nine countries, focusing on identifying barriers and opportunities to improve oxygen access for patients. It involves a series of mixed-methods assessments to evaluate current practices and institutional readiness for oxygen service delivery, particularly for children suffering from severe hypoxemia. The program seeks to strengthen oxygen systems through tailored interventions that address local challenges in healthcare delivery. By collaborating with Ministries of Health and local institutions, the study aims to enhance the capacity of healthcare workers and improve oxygen service governance.
Why it matters
Potential benefit: If successful, this program could significantly improve access to life-saving oxygen therapy for vulnerable populations, particularly children with severe respiratory conditions.
How similar studies have gone: Other studies have shown success in improving oxygen access and management in similar low-resource settings, indicating that this approach has potential for positive outcomes.
Who can join: the full rules
Show full inclusion / exclusion criteria
Sub-study 1: Research Question: What are the baseline pulse oximetry and oxygen practices for children admitted to participating health facilities, and what is the level of institutional readiness for oxygen service delivery? Which facilities, representative of high- and low-performing facilities and different levels of care and facility types, can be selected for additional investigation to understand current functioning of oxygen systems? Setting and Population: The broader MOXY program baseline cross-sectional assessments involve 9 countries. We have selected 6 MOXY countries for the mixed methods studies outlined in this protocol - Nigeria, Uganda, Liberia, Rwanda, Cambodia and Lao PDR - based on pre-existing research collaborations, and with the aim of representing broadly different geographical contexts. Baseline assessments are being conducted in all facilities participating in the MOXY program in each of the 6 study countries. From this data set, we will analyse primary and secondary outcomes for wards caring for children \<15 years (including neonatal wards where relevant). Analysis/outcomes: Primary - proportion of admitted children (\<15 years, including neonates) screened with pulse oximetry. Secondary - proportion of admitted children with hypoxaemia (\<15 years, including neonates) treated with oxygen. For Real-Moxy the secondary outcome will inform identification of facilities for inclusion. Sub-study 2: Research question: Where and how are patients managed from arrival to admission and discharge (or transfer), and how does oxygen equipment move within and between clinical areas? How do process maps vary for different clinical scenarios representing different patient groups: i) pneumonia with and without hypoxaemia; ii) severe, acute illness syndrome with WHO emergency signs (e.g., shock, multi-trauma, seizures); iii) surgical condition and iv) neonatal illness (inborn and outborn)? Setting and Population: This will be conducted in 10 health facilities in each of the 6 countries (Nigeria, Uganda, Liberia, Rwanda, Lao PDR, Cambodia), selected to represent high and low functioning facility oxygen systems and include secondary and tertiary health facilities from government and non-governmental sectors (identified in sub-study 1). We will focus on admitted children (\<15 years, including neonates) with (i) pneumonia, (ii) other acute illness with WHO emergency signs, (iii) surgical conditions, and (iv) neonatal illness. We have chosen these conditions to represent diagnoses with a high prevalence of hypoxaemia, and to capture the nuances of how pulse oximetry and oxygen practices are adapted (or not adapted) to clinical scenarios (e.g., having a lower threshold to provide oxygen to a patient in shock; or targeting safe oxygen saturations in neonates). Analysis/outcomes: Facility maps of patient and equipment flow. Sub-study 3: Research question: What is the sequence of emergency care for an unwell child in the first 4 hours, and how are decisions made - particularly relating to oxygen (when to start, stop, how much, what delivery modality, etc.)? What are the points of delays to appropriate care (including pulse oximetry and oxygen) and at what points in time and location could pulse oximetry and oxygen be used better for emergency care of children? Setting and Population: facilities are same as sub-study 2). Children (\<15 years, including neonates) presenting with each of 4 acute illness syndromes: (i) pneumonia, (ii) other acute illness with WHO emergency signs, (iii) surgical conditions, and (iv) neonatal illness. Analysis/outcomes: Patient journey maps. Sub-study 4: Research question: How do healthcare workers use pulse oximetry and oxygen for admitted patients, and how does this change over time and vary between patient groups, facility type, and location? How do practices compare with treatment guidelines and where are the priority areas for improving oxygen care? Population and setting: Facilities are same as sub-studies 2\&3. Analysis/outcomes: Narrative descriptions of handover, ward rounds, and nursing rounds, with specific emphasis on how pulse oximetry is used, and decision making for oxygen therapy. Sub-study 5: Indepth interviews and focus group discussions Research questions: 5a) How do patients/caregivers perceive pulse oximetry and oxygen therapy within their broader care experience? 5b) How do healthcare workers, managers and technicians perceive oxygen therapy and the provision of oxygen-related care within the broader care provision experience? Population: * Patients and caregivers enrolled in sub-study 3 (patient journey mapping). * Healthcare workers (bedside), managers (including clinical and non-clinical managers) and technicians in each health facility. We will select staff with direct responsibility for wards caring for children \<15 years. Analysis/outcomes: Reflexive thematic analysis of interviews and focus group discussions.
Where it's running
-
10 Facilities to Be Selected
Phnom Penh, Cambodia Recruiting -
10 Facilities to Be Selected
Ibadan, Nigeria Active not recruiting -
10 Facilities to Be Selected
Kampala, Uganda Active not recruiting
Study contacts
- Principal investigator: Hamish Graham, PhD — Murdoch Childrens Research Institute
- Study coordinator: Rami Subhi, FRACP
- Email: rami.subhi@mcri.edu.au
- Phone: +61403151186
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Evaluating medical oxygen access and policies
This study looks at how access to medical oxygen works in six countries to see what challenges people face and how to improve it for patients and healthcare providers.
-
Sulbactam-Durlobactam for CRAB infections in real-world care
This real-world study tests whether sulbactam-durlobactam works and is safe for adults with carbapenem-resistant Acinetobacter baumannii infections, compared with other anti-CRAB treatments.
-
Safety and performance of the INBENTUS VERSATILE ventilator in adults on invasive mechanical ventilation
This trial will test whether the INBENTUS VERSATILE ventilator is safe and performs well in adults who need assisted or controlled invasive mechanical ventilation and short-term weaning.
-
Effects of suctioning on pain and stress in intubated ICU patients
This study is testing if suctioning the breathing tube in ICU patients causes more pain and stress compared to not suctioning.
-
Understanding risk factors and biomarkers in ARDS, sepsis, and pneumonia
This study is trying to find out what causes acute respiratory distress syndrome, sepsis, and pneumonia by collecting health information and samples from hospitalized adults to help improve treatment for these conditions.
-
Validation of hematological indices in cardiac surgery patients
This study is testing if certain blood test results can help predict infections and organ problems in patients who are having heart surgery.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.